New injection shows promise for slowing type 1 diabetes progression
Disease control
Recruiting now
This study tests a new drug called OPT101 in people recently diagnosed with type 1 diabetes. The goal is to see if it can help preserve the body's ability to make insulin, reducing the need for injected insulin. Participants will receive injections three times a week for up to a …
Phase: PHASE2 • Sponsor: Op-T LLC • Aim: Disease control
Last updated May 01, 2026 21:57 UTC